IP Library Granted Patent US 7,070,772
Granted Patent B2
US 7,070,772 · App. 09/908,299 · Granted Jul 4, 2006

Salicylic acid biosynthetic genes and uses thereof

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,070,772
App. No.
09/908,299
Granted
Jul 4, 2006
Kind
B2
Abstract

The invention provides methods for inducing or increasing disease resistance in a plant. The invention also features methods of using a plant having a mutation in an inducible isochorismate synthase to determine if the success of a pathogen in infecting a plant is affected by a plant disease resistance pathway involving isochorismate synthase.

Claims (6)

1. A method for determining whether the success of a pathogen in infecting a plant is affected by a plant disease resistance pathway involving isochorismate synthase, the method comprising the steps of:

(a) contacting a mutant Arabidopsis thaliana plant comprising a sid-2-2 mutation with a pathogen; and

(b) assessing the level of infection of the mutant plant with the pathogen, compared to a control Arabidopsis thaliana plant containing a wild-type inducible isochorismate synthase gene, wherein an altered degree of pathogen infection or disease symptoms in the mutant plant, as compared to the control plant, indicates that the success of the pathogen in infecting the control plant is affected by a plant disease resistance pathway involving isochorismate synthase.

2. A method for determining whether a pathogen induces a plant disease resistance pathway involving isochorismate synthase in a plant, the method comprising the steps of:

(a) contacting a mutant Arabidopsis thaliana plant comprising a sid-2-2 mutation with a pathogen, and

detecting the level of salicylic acid produced in the mutant plant, where detection of decreased levels of salicylic acid in the mutant plant, compared to a control Arabidopsis thaliana plant comprising a wild-type inducible isochorismate synthase gene, indicates that the pathogen induces a disease resistance pathway involving isochorismate synthase in the plant.

Assignments (5)
CONFIRMATORY LICENSE Recorded Feb 4, 2019
From: THE GENERAL HOSPITAL CORPORATION
To: NIH - DEITR
Reel/Frame 048226/0362 →
CONFIRMATORY LICENSE Recorded May 19, 2009
From: GENERAL HOSPITAL CORPORATION DBA MASS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022700/0537 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Aug 6, 2008
From: GENERAL HOSPITAL CORPORATION DBA MASS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021339/0313 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2002
From: WILDERMUTH, MARY C.; AUSUBEL, FREDERICK M.; DEWDNEY, JULIA
To: GENERAL HOSPITAL CORPORATION, THE
Reel/Frame 012993/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2002
From: XU, QI; QI, TAO; MEASAMER, JEFFREY C.
To: CSO AKER MARINE CONTRACTORS, INC.
Reel/Frame 012457/0428 →
Continuity (2)
Provisional Application 6021923100 · Jul 18, 2000
Related Publication 20030051273A1 · Mar 13, 2003